TSE:TH - Theratechnologies Stock Price, Price Target & More

C$9.38 +0.19 (+2.07 %)
(As of 04/23/2018 04:00 PM ET)
Previous CloseC$9.38
Today's RangeC$9.22 - C$9.44
52-Week RangeC$4.96 - C$10.05
Volume159,100 shs
Average Volume154,621 shs
Market CapitalizationC$737.77 million
P/E RatioN/A
Dividend YieldN/A
Beta0.52

About Theratechnologies (TSE:TH)

Theratechnologies logoTheratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. The company's lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada. Theratechnologies Inc. was founded in 1993 and is headquartered in Montreal, Canada.

Receive TH News and Ratings via Email

Sign-up to receive the latest news and ratings for TH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolTSE:TH
CUSIPN/A
Phone+1-514-3367800

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-33.47%
Return on Equity-38.09%
Return on Assets-22.70%

Miscellaneous

EmployeesN/A
Outstanding Shares74,962,000

How to Become a New Pot Stock Millionaire

Theratechnologies (TSE:TH) Frequently Asked Questions

What is Theratechnologies' stock symbol?

Theratechnologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TH."

How were Theratechnologies' earnings last quarter?

Theratechnologies (TSE:TH) released its quarterly earnings data on Wednesday, February, 7th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.04) by $0.02. The business earned $12.60 million during the quarter, compared to analyst estimates of $11.70 million. Theratechnologies had a negative net margin of 33.47% and a negative return on equity of 38.09%. View Theratechnologies' Earnings History.

When is Theratechnologies' next earnings date?

Theratechnologies is scheduled to release their next quarterly earnings announcement on Wednesday, July, 11th 2018. View Earnings Estimates for Theratechnologies.

What price target have analysts set for TH?

3 Wall Street analysts have issued twelve-month price objectives for Theratechnologies' shares. Their forecasts range from C$9.25 to C$15.00. On average, they expect Theratechnologies' stock price to reach C$12.06 in the next year. View Analyst Ratings for Theratechnologies.

Who are some of Theratechnologies' key competitors?

Who are Theratechnologies' key executives?

Theratechnologies' management team includes the folowing people:
  • Mr. Luc Tanguay, Chief Exec. Officer, Pres and Non-Independent Director (Age 60)
  • Mr. Philippe Dubuc, Sr. VP & CFO (Age 51)
  • Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 50)
  • Mr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 55)
  • Ms. Lyne Fortin, Sr. VP & Chief Commercial Officer (Age 58)

Has Theratechnologies been receiving favorable news coverage?

News coverage about TH stock has been trending somewhat positive on Monday, Accern reports. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Theratechnologies earned a media sentiment score of 0.22 on Accern's scale. They also assigned press coverage about the company an impact score of 45.94 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of Theratechnologies?

Shares of TH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Theratechnologies' stock price today?

One share of TH stock can currently be purchased for approximately C$9.38.

How big of a company is Theratechnologies?

Theratechnologies has a market capitalization of C$737.77 million.

How can I contact Theratechnologies?

Theratechnologies' mailing address is 2015 Peel St 5th Floor, MONTREAL, QC H3A 1T8, Canada. The company can be reached via phone at +1-514-3367800.


MarketBeat Community Rating for Theratechnologies (TH)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  100 (Vote Outperform)
Underperform Votes:  135 (Vote Underperform)
Total Votes:  235
MarketBeat's community ratings are surveys of what our community members think about Theratechnologies and other stocks. Vote "Outperform" if you believe TH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Theratechnologies (TSE:TH) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Theratechnologies in the last 12 months. Their average twelve-month price target is C$12.06, suggesting that the stock has a possible upside of 28.60%. The high price target for TH is C$15.00 and the low price target for TH is C$9.25. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.672.672.67
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: C$12.06C$12.06C$8.50C$8.83
Price Target Upside: 28.60% upside28.46% upside15.96% upside12.38% upside

Theratechnologies (TSE:TH) Consensus Price Target History

Price Target History for Theratechnologies (TSE:TH)

Theratechnologies (TSE:TH) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
3/7/2018National Bank FinancialBoost Price TargetOutperformC$8.75 -> C$11.00View Rating Details
3/7/2018Canaccord GenuityBoost Price TargetC$9.50 -> C$13.00View Rating Details
3/7/2018CIBCBoost Price TargetC$10.30 -> C$15.00View Rating Details
10/6/2017ScotiabankLower Price TargetOutperformC$10.00 -> C$9.25View Rating Details
7/6/2016MackieLower Price TargetC$5.30 -> C$4.40View Rating Details
(Data available from 4/23/2016 forward)

Earnings

Theratechnologies (TSE:TH) Earnings History and Estimates Chart

Earnings by Quarter for Theratechnologies (TSE:TH)

Theratechnologies (TSE TH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/11/2018        
2/7/2018Q4 2017C($0.04)C($0.06)C$11.70 millionC$12.60 millionViewN/AView Earnings Details
10/5/2017Q3 2017C($0.03)C($0.04)C$11.00 millionC$11.22 millionViewN/AView Earnings Details
7/12/2017Q2 2017C($0.03)C($0.13)C$11.20 millionC$10.02 millionViewN/AView Earnings Details
4/6/2017Q1 2017C($0.01)C($0.03)C$10.60 millionC$9.04 millionViewN/AView Earnings Details
10/4/2016Q3 2016C$0.01C$0.01C$9.45 millionC$8.93 millionViewN/AView Earnings Details
7/5/2016Q2 2016C$0.02C($0.01)C$11.75 millionC$9.03 millionViewN/AView Earnings Details
2/24/2016Q4 2015C$0.03C$0.01C$10.50 millionC$9.01 millionViewN/AView Earnings Details
10/1/2015Q3 2015C$0.02C$9.19 millionViewN/AView Earnings Details
7/14/2015Q2C($0.02)C$0.01C$6.45 millionC$7.08 millionViewListenView Earnings Details
4/14/2015Q1 2015C($0.03)C($0.01)C$4.02 millionC$4.57 millionViewN/AView Earnings Details
2/26/2015Q4 2014C($0.09)C($0.06)C$2.33 millionC$2.66 millionViewN/AView Earnings Details
10/8/2014Q3 2014C($0.07)ViewN/AView Earnings Details
7/9/2014Q2 2014C$0.02C$2.39 millionViewN/AView Earnings Details
4/14/2014Q1 2014C($0.06)C$1.67 millionViewN/AView Earnings Details
2/27/2014Q4 2013C($0.04)C$1.25 millionViewN/AView Earnings Details
10/10/2013Q3 2013C($0.03)C$2.18 millionViewN/AView Earnings Details
7/10/2013Q2 2013C($0.02)C$2.33 millionViewN/AView Earnings Details
2/27/2013Q4 2012C($0.02)ViewN/AView Earnings Details
10/11/2012Q3 2012C($0.02)C($0.01)ViewN/AView Earnings Details
7/12/2012Q2 2012C($0.02)C($0.02)ViewN/AView Earnings Details
4/13/2012Q1 2012C($0.07)C($0.06)ViewN/AView Earnings Details
2/8/2012Q4 2011C($0.07)C($0.03)ViewN/AView Earnings Details
10/13/2011Q3 2011C($0.08)C($0.06)ViewN/AView Earnings Details
7/7/2011Q2 2011C($0.06)C($0.10)ViewN/AView Earnings Details
4/12/2011Q1 2011C($0.04)C($0.10)ViewN/AView Earnings Details
10/12/2010Q3 2010C($0.09)C($0.08)ViewN/AView Earnings Details
7/7/2010Q2 2010C($0.07)C($0.11)ViewN/AView Earnings Details
3/23/2010Q1 2010C($0.09)C($0.07)ViewN/AView Earnings Details
2/10/2010Q4 2009C($0.09)C($0.11)ViewN/AView Earnings Details
10/5/2009Q3 2009C($0.07)C($0.11)ViewN/AView Earnings Details
7/7/2009Q2 2009C($0.12)C($0.09)ViewN/AView Earnings Details
2/9/2009Q4 2008C$0.32C($0.17)ViewN/AView Earnings Details
7/9/2008Q2 2008C($0.20)ViewN/AView Earnings Details
3/25/2008Q1 2008C($0.20)C($0.20)ViewN/AView Earnings Details
1/23/2008Q4 2007C($0.12)C($0.19)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Theratechnologies (TSE:TH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Theratechnologies (TSE TH) Insider Trading and Institutional Ownership History

Insider Trading History for Theratechnologies (TSE:TH)

Theratechnologies (TSE TH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/10/2018Lyne FortinInsiderSell1,000C$9.37C$9,370.00
4/9/2018Jean-Denis TalonDirectorBuy2,700C$9.44C$25,488.00
4/6/2018Denis BoucherInsiderBuy400C$9.51C$3,804.00
11/15/2017Luc TanguayDirectorBuy2,300C$6.64C$15,272.00
11/15/2017Philippe DubucInsiderBuy1,000C$6.66C$6,660.00
7/18/2017Christian MarsolaisInsiderBuy3,000C$7.12C$21,360.00
7/17/2017Philippe DubucInsiderBuy1,000C$8.00C$8,000.00
5/24/2017Philippe DubucInsiderBuy600C$6.42C$3,852.00
4/7/2017Philippe DubucInsiderBuy400C$5.89C$2,356.00
7/7/2016G�Rald A LacosteDirectorBuy4,000C$2.36C$9,440.00
4/8/2016Philippe DubucInsiderBuy3,300C$2.00C$6,600.00
4/7/2016Pierre PerazzelliDirectorSell7,700C$1.95C$15,015.00
4/6/2016Pierre PerazzelliDirectorSell6,500C$0.38C$2,470.00
4/5/2016Marie-No�L ColussiInsiderSell10,000C$2.04C$20,384.00
4/5/2016Pierre PerazzelliDirectorSell6,500C$2.05C$13,325.00
6/26/2015G�Rald A LacosteDirectorBuy10,000C$1.47C$14,700.00
5/22/2015Paul PommierDirectorBuy20,300C$1.40C$28,420.00
5/21/2015Paul PommierDirectorBuy25,000C$1.38C$34,500.00
5/5/2015Dawn SvoronosDirectorBuy5,000C$1.26C$6,300.00
5/1/2015Lyne FortinInsiderBuy9,900C$1.23C$12,177.00
4/30/2015Luc TanguayDirectorBuy4,100C$1.19C$4,879.00
(Data available from 1/1/2013 forward)

Headlines

Theratechnologies (TSE TH) News Headlines

Source:
DateHeadline
Theratechnologies Inc (TH) Director Jean-Denis Talon Acquires 2,700 SharesTheratechnologies Inc (TH) Director Jean-Denis Talon Acquires 2,700 Shares
www.americanbankingnews.com - April 9 at 4:12 PM
FY2018 EPS Estimates for Theratechnologies Inc (TH) Decreased by AnalystFY2018 EPS Estimates for Theratechnologies Inc (TH) Decreased by Analyst
www.americanbankingnews.com - April 9 at 1:54 AM
BRIEF-Theratechnologies Reports Q1 Loss Per Share C$0.04BRIEF-Theratechnologies Reports Q1 Loss Per Share C$0.04
www.reuters.com - April 5 at 8:18 AM
Theratechnologies Announces Financial Results for First Quarter of 2018Theratechnologies Announces Financial Results for First Quarter of 2018
finance.yahoo.com - April 5 at 8:18 AM
Theratechnologies (TH) Scheduled to Post Earnings on ThursdayTheratechnologies (TH) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - April 2 at 10:28 AM
Theratechnologies to Announce Financial Results for First Quarter 2018Theratechnologies to Announce Financial Results for First Quarter 2018
finance.yahoo.com - March 29 at 3:57 PM
New Positive Data on Trogarzo™ (ibalizumab-uiyk) Injection and EGRIFTA® (tesamorelin for injection) Presented at ... - GlobeNewswire (press release)New Positive Data on Trogarzo™ (ibalizumab-uiyk) Injection and EGRIFTA® (tesamorelin for injection) Presented at ... - GlobeNewswire (press release)
globenewswire.com - March 9 at 11:17 AM
National Bank Financial Analysts Lower Earnings Estimates for Theratechnologies Inc (TH)National Bank Financial Analysts Lower Earnings Estimates for Theratechnologies Inc (TH)
www.americanbankingnews.com - March 9 at 10:17 AM
Pollard, Theratechnologies at 52-Week HighsPollard, Theratechnologies at 52-Week Highs
www.baystreet.ca - March 8 at 4:36 PM
Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-uiyk) Injection, the ... - PR Newswire (press release)Theratechnologies Announces FDA Approval of Breakthrough Therapy, Trogarzo™ (ibalizumab-uiyk) Injection, the ... - PR Newswire (press release)
www.prnewswire.com - March 7 at 4:37 PM
Theratechnologies (TH) PT Raised to C$15.00Theratechnologies (TH) PT Raised to C$15.00
www.americanbankingnews.com - March 7 at 3:08 PM
Canaccord Genuity Boosts Theratechnologies (TH) Price Target to C$13.00Canaccord Genuity Boosts Theratechnologies (TH) Price Target to C$13.00
www.americanbankingnews.com - March 7 at 2:49 PM
Theratechnologies (TH) Price Target Raised to C$11.00Theratechnologies (TH) Price Target Raised to C$11.00
www.americanbankingnews.com - March 7 at 2:49 PM
IIROC Trading Halt - THIIROC Trading Halt - TH
www.bizjournals.com - March 6 at 4:20 PM
Theratechnologies Inc (TH) Forecasted to Post FY2019 Earnings of $0.43 Per ShareTheratechnologies Inc (TH) Forecasted to Post FY2019 Earnings of $0.43 Per Share
www.americanbankingnews.com - February 12 at 8:28 AM
Theratechnologies Inc (TH) to Post FY2018 Earnings of $0.13 Per Share, National Bank Financial ForecastsTheratechnologies Inc (TH) to Post FY2018 Earnings of $0.13 Per Share, National Bank Financial Forecasts
www.americanbankingnews.com - February 9 at 12:28 PM
Theratechnologies to Announce Financial Results for Fiscal Year 2017Theratechnologies to Announce Financial Results for Fiscal Year 2017
finance.yahoo.com - February 7 at 8:46 AM
Theratechnologies Announces Financial Results for Fiscal Year 2017Theratechnologies Announces Financial Results for Fiscal Year 2017
finance.yahoo.com - February 7 at 8:46 AM
Theratechnologies, Inc. breached its 50 day moving average in a Bullish Manner : TH-CA : December 29, 2017Theratechnologies, Inc. breached its 50 day moving average in a Bullish Manner : TH-CA : December 29, 2017
finance.yahoo.com - December 29 at 7:40 AM
Brokers Set Expectations for Theratechnologies Inc.s FY2018 Earnings (TH)Brokers Set Expectations for Theratechnologies Inc.'s FY2018 Earnings (TH)
www.americanbankingnews.com - November 18 at 8:52 AM
Theratechnologies Inc. (TH) Director Luc Tanguay Purchases 2,300 SharesTheratechnologies Inc. (TH) Director Luc Tanguay Purchases 2,300 Shares
www.americanbankingnews.com - November 15 at 9:59 PM
Theratechnologies, Inc. – Value Analysis (TORONTO:TH) : November 14, 2017Theratechnologies, Inc. – Value Analysis (TORONTO:TH) : November 14, 2017
finance.yahoo.com - November 15 at 2:43 PM
Theratechnologies Inc. (TH) Price Target Cut to C$8.75Theratechnologies Inc. (TH) Price Target Cut to C$8.75
www.americanbankingnews.com - November 14 at 2:28 PM
Theratechnologies, Inc. breached its 50 day moving average in a Bearish Manner : TH-CA : November 13, 2017Theratechnologies, Inc. breached its 50 day moving average in a Bearish Manner : TH-CA : November 13, 2017
finance.yahoo.com - November 14 at 9:36 AM
Theratechnologies Announces Decision by the FDA to Extend the Ibalizumab Review Period to April 3, 2018Theratechnologies Announces Decision by the FDA to Extend the Ibalizumab Review Period to April 3, 2018
finance.yahoo.com - November 14 at 9:36 AM
Calculating The Fair Value Of Theratechnologies Inc (TSX:TH)Calculating The Fair Value Of Theratechnologies Inc (TSX:TH)
finance.yahoo.com - November 5 at 7:05 AM
Theratechnologies, Inc. breached its 50 day moving average in a Bearish Manner : TH-CA : October 27, 2017Theratechnologies, Inc. breached its 50 day moving average in a Bearish Manner : TH-CA : October 27, 2017
finance.yahoo.com - October 27 at 4:21 PM
Daily Coverage on Healthcare Stocks, Concordia International, ProMetic Life Sciences, Theratechnologies and Cardiome PharmaDaily Coverage on Healthcare Stocks, Concordia International, ProMetic Life Sciences, Theratechnologies and Cardiome Pharma
finance.yahoo.com - October 23 at 8:15 AM
Theratechnologies, Inc. :TH-CA: Earnings Analysis: Q3, 2017 By the Numbers : October 9, 2017Theratechnologies, Inc. :TH-CA: Earnings Analysis: Q3, 2017 By the Numbers : October 9, 2017
finance.yahoo.com - October 10 at 7:26 AM
Research Analysts Set Expectations for Theratechnologies Incs FY2018 Earnings (TH)Research Analysts Set Expectations for Theratechnologies Inc's FY2018 Earnings (TH)
www.americanbankingnews.com - October 9 at 6:22 AM
Theratechnologies Inc (TH) Rating Increased to Outperform Market Weight at National Bank FinancialTheratechnologies Inc (TH) Rating Increased to Outperform Market Weight at National Bank Financial
www.americanbankingnews.com - October 7 at 6:36 AM
Scotiabank Lowers Theratechnologies Inc (TH) Price Target to C$9.25Scotiabank Lowers Theratechnologies Inc (TH) Price Target to C$9.25
www.americanbankingnews.com - October 6 at 1:46 PM
Theratechnologies Inc (TH) Given New C$9.75 Price Target at National Bank FinancialTheratechnologies Inc (TH) Given New C$9.75 Price Target at National Bank Financial
www.americanbankingnews.com - October 6 at 1:44 PM
Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™ - PR Newswire (press release)Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™ - PR Newswire (press release)
www.prnewswire.com - October 6 at 11:17 AM
Theratechnologies Announces Financial Results for Third Quarter of 2017Theratechnologies Announces Financial Results for Third Quarter of 2017
finance.yahoo.com - October 6 at 11:17 AM
Theratechnologies reports 3Q lossTheratechnologies reports 3Q loss
finance.yahoo.com - October 6 at 11:17 AM
Edited Transcript of TH.TO earnings conference call or presentation 5-Oct-17 12:30pm GMTEdited Transcript of TH.TO earnings conference call or presentation 5-Oct-17 12:30pm GMT
finance.yahoo.com - October 6 at 11:17 AM
Equities Analysts Issue Forecasts for Theratechnologies Incs Q3 2017 Earnings (TH)Equities Analysts Issue Forecasts for Theratechnologies Inc's Q3 2017 Earnings (TH)
www.americanbankingnews.com - October 6 at 7:14 AM
Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017(TM)Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017(TM)
finance.yahoo.com - October 4 at 10:06 AM
Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™
finance.yahoo.com - October 4 at 10:06 AM
Theratechnologies to Announce Financial Results for the Third Quarter of 2017Theratechnologies to Announce Financial Results for the Third Quarter of 2017
finance.yahoo.com - October 3 at 1:30 PM
Todays Research Reports on Theratechnologies, Aphria, Aurinia Pharmaceuticals and Theralase TechnologiesToday's Research Reports on Theratechnologies, Aphria, Aurinia Pharmaceuticals and Theralase Technologies
finance.yahoo.com - October 3 at 1:30 PM
Theratechnologies Inc (TH) Scheduled to Post Quarterly Earnings on ThursdayTheratechnologies Inc (TH) Scheduled to Post Quarterly Earnings on Thursday
www.americanbankingnews.com - September 28 at 1:04 AM
Ibalizumab Long-Term Safety and Efficacy Data to be Presented at IDWeek 2017 in San DiegoIbalizumab Long-Term Safety and Efficacy Data to be Presented at IDWeek 2017 in San Diego
finance.yahoo.com - September 19 at 8:25 AM
5 Biotech Innovators Set To Excel In 20175 Biotech Innovators Set To Excel In 2017
www.baystreet.ca - September 14 at 11:16 AM
Biotech Breakthroughs: 5 Stocks To Watch In 2017Biotech Breakthroughs: 5 Stocks To Watch In 2017
www.baystreet.ca - September 12 at 10:57 AM
Canadian Healthcare Stocks Under Review, Concordia International, ProMetic Life Sciences, Theratechnologies, and Cardiome PharmaCanadian Healthcare Stocks Under Review, Concordia International, ProMetic Life Sciences, Theratechnologies, and Cardiome Pharma
finance.yahoo.com - August 17 at 8:17 AM
Edited Transcript of TH.TO earnings conference call or presentation 12-Jul-17 12:30pm GMTEdited Transcript of TH.TO earnings conference call or presentation 12-Jul-17 12:30pm GMT
finance.yahoo.com - August 14 at 6:16 AM
Theratechnologies Issues Reminder Regarding Warrant ExpiryTheratechnologies Issues Reminder Regarding Warrant Expiry
finance.yahoo.com - August 4 at 9:02 AM
Theratechnologies’ shares on upward trajectory as new drugs move closer to marketTheratechnologies’ shares on upward trajectory as new drugs move closer to market
www.theglobeandmail.com - August 3 at 7:54 AM

SEC Filings

Theratechnologies (TSE:TH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Theratechnologies (TSE TH) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.